Newswire

Tag: low-enriched uranium

Japan-to-U.S. HEU transfer fulfills nonproliferation commitment

August 10, 2022, 3:02PMNuclear News
NNSA administrator Jill Hruby (right) and Ken Nakajima, director of the Institute for Integrated Radiation and Nuclear Science at Kyoto University, in the KUCA control room. (Photo: NNSA)

All high-enriched uranium has been removed from the Kyoto University Critical Assembly (KUCA), according to an announcement from the U.S. Department of Energy’s National Nuclear Security Administration.

Thinking inside the box

May 22, 2020, 3:42PMRadwaste SolutionsTim Gregoire

The Optimus-H transport cask on display at the 2020 Waste Management Conference in Phoenix, Ariz.

Jeff England, director of transportation projects for NAC International, pointed to the large stainless steel canister, which looked like a giant-­sized silver dumbbell, perched on the flatbed of a semitrailer truck parked in the middle of the expansive exhibit hall in the Phoenix Convention Center. NAC, a provider of nuclear storage, transportation, and consulting services, was using the 2020 Waste Management Conference, held March 8–12 in Phoenix, Ariz., to unveil its newest transport casks, the Optimus-­H and Optimus-­L.

“These are a different niche,” England said of the casks, which were designed to transport radioactive materials, including remote-­handled transuranic waste, high-­activity intermediate-­level waste, low-­enriched uranium, and fissile materials. “You have a lot of [small] drum-­sized packages, and you also have a lot of big packages that will hold around 10 55-­gallon drums. But there’s not anything in between. We hold a 110-­gallon drum capacity.”

IRE produces first batch of LEU-based Mo-99

May 6, 2020, 8:51AMNuclear News

Belgium’s National Institute of Radioelements (IRE) announced on April 30 that it has produced its first batch of commercial molybdenum-99 from low-enriched uranium (LEU) targets. The first batch of Mo-99, whose decay product, technetium-99m, is used in nuclear medicine for diagnostic imaging, was produced for the U.S. health market. IRE said that the conversion to LEU represents a key milestone for the institute in the global commitment to end the civilian use of highly enriched uranium (HEU) for the production of Mo-99.